1. Home
  2. OVID vs INLX Comparison

OVID vs INLX Comparison

Compare OVID & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • INLX
  • Stock Information
  • Founded
  • OVID 2014
  • INLX 1996
  • Country
  • OVID United States
  • INLX United States
  • Employees
  • OVID N/A
  • INLX N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • INLX EDP Services
  • Sector
  • OVID Health Care
  • INLX Technology
  • Exchange
  • OVID Nasdaq
  • INLX Nasdaq
  • Market Cap
  • OVID 54.1M
  • INLX 54.2M
  • IPO Year
  • OVID 2017
  • INLX N/A
  • Fundamental
  • Price
  • OVID $0.74
  • INLX $12.88
  • Analyst Decision
  • OVID Strong Buy
  • INLX
  • Analyst Count
  • OVID 5
  • INLX 0
  • Target Price
  • OVID $4.04
  • INLX N/A
  • AVG Volume (30 Days)
  • OVID 384.9K
  • INLX 3.7K
  • Earning Date
  • OVID 03-07-2025
  • INLX 11-13-2024
  • Dividend Yield
  • OVID N/A
  • INLX N/A
  • EPS Growth
  • OVID N/A
  • INLX N/A
  • EPS
  • OVID N/A
  • INLX N/A
  • Revenue
  • OVID $631,695.00
  • INLX $17,930,991.00
  • Revenue This Year
  • OVID $71.38
  • INLX $8.35
  • Revenue Next Year
  • OVID $5,144.81
  • INLX $6.48
  • P/E Ratio
  • OVID N/A
  • INLX N/A
  • Revenue Growth
  • OVID 113.21
  • INLX 7.17
  • 52 Week Low
  • OVID $0.68
  • INLX $4.99
  • 52 Week High
  • OVID $4.10
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • OVID 25.31
  • INLX 41.52
  • Support Level
  • OVID $0.75
  • INLX $12.62
  • Resistance Level
  • OVID $1.01
  • INLX $13.27
  • Average True Range (ATR)
  • OVID 0.07
  • INLX 0.62
  • MACD
  • OVID -0.02
  • INLX -0.11
  • Stochastic Oscillator
  • OVID 6.25
  • INLX 18.59

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

Share on Social Networks: